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Abstract
Human induced pluripotent stem (hiPS) cells offer a novel source of patient-specific cells for regenerative medicine.
However, the biological potential of iPS-derived cells and their similarities to cells differentiated from human embryonic
stem (hES) cells remain unclear. We derived fibroblast-like cells from two hiPS cell lines and show that their phenotypic
properties and patterns of DNA methylation were similar to that of mature fibroblasts and to fibroblasts derived from hES
cells. iPS-derived fibroblasts (iPDK) and their hES-derived counterparts (EDK) showed similar cell morphology throughout
differentiation, and patterns of gene expression and cell surface markers were characteristic of mature fibroblasts. Array-
based methylation analysis was performed for EDK, iPDK and their parental hES and iPS cell lines, and hierarchical clustering
revealed that EDK and iPDK had closely-related methylation profiles. DNA methylation analysis of promoter regions
associated with extracellular matrix (ECM)-production (COL1A1) by iPS- and hESC-derived fibroblasts and fibroblast lineage
commitment (PDGFRb), revealed promoter demethylation linked to their expression, and patterns of transcription and
methylation of genes related to the functional properties of mature stromal cells were seen in both hiPS- and hES-derived
fibroblasts. iPDK cells also showed functional properties analogous to those of hES-derived and mature fibroblasts, as seen
by their capacity to direct the morphogenesis of engineered human skin equivalents. Characterization of the functional
behavior of ES- and iPS-derived fibroblasts in engineered 3D tissues demonstrates the utility of this tissue platform to
predict the capacity of iPS-derived cells before their therapeutic application.
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Introduction
Human induced pluripotent stem (hiPS) cells have great
potential to generate patient-specific cells that may serve as a
robust source of progenitors for regenerative medicine. It has
recently been shown that iPS cells are similar in their patterns of
gene expression and epigenetic profile to embryonic stem cells [1],
in spite of evidence showing phenotypic differences between them
[2–5]. In this light, it is particularly important to determine if
specific cell types derived from iPS and human ES (hES) cells,
using the same derivation strategies, will generate cells with similar
functional features. Using protocols initially established for hES
cell differentiation, it has been shown that hiPS reprogrammed
from adult fibroblasts can be directed into specific cell types and
lineages [4,6–8]. However, it remains unclear if the molecular and
cellular features that direct the biological potential and functional
behavior are restored in a characteristic manner once hiPS cells
are differentiated towards a fibroblast lineage.
We have recently reported a protocol to efficiently derive cells
from hES cells that show phenotypic and functional features of
human stromal fibroblasts [9]. Stromal fibroblasts support the
development, repair and homeostasis of their resident tissues [10]
and understanding their differentiation from hES and hiPS will be
critical to designing effective strategies for their use in future
regenerative therapies [11]. Several methods have been estab-
lished to generate cells with features of mesenchymal stem cell
(MSC)-like cells from hES cells [12–14]. However, due to an
incomplete understanding of fibroblast development from MSCs
and to their cellular heterogeneity in vivo that results in a lack of
definitive markers needed to isolate them [15,16], realization of
the therapeutic potential of fibroblasts has been limited [17]. In
light of this, stromal fibroblasts derived from hES or iPS may serve
as an alternative source of more uniform, well-characterized
stromal cells that can offer predictable tissue outcomes. Beyond
this, the possibility that MSCs derived from iPS might acquire a
biological potency that would exceed that of the fibroblasts from
which they were originally derived [18–20], raises further interest
in characterizing iPS as a source of stromal fibroblasts.
During the process of reprogramming of human somatic cells to
hiPS, cells undergo dramatic epigenetic changes that include
recalibration of DNA methylation that resets transcriptional
programs [1,21]. The subsequent differentiation of iPS cells to
mature cell types is dependent on reestablishment of methylation
marks that govern patterns of gene expression to give stable,
functional cell types [22,23]. As a result, mature cell types derived
from these pluripotent sources acquire unique DNA methylation
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differential methylation between human pluripotent stem cells and
cells differentiated from them hold promise for revealing the
underlying basis for how lineage specification occurs upon
activation of developmental programs [26]. DNA methylation
analyses can also be used to compare the normalization of iPS-
derived cells to the somatic cell population from which iPS were
originally reprogrammed. For this reason, determining the
similarities or differences in the status of CpG promoter
methylation for a specific cell type differentiated from both hES
and hiPS is important for their characterization. Whole-genome
DNA methylation analysis has been used recently to compare
methylation and associated patterns of gene expression between
hES and cells derived from them [27], and has demonstrated a
global shift towards methylation and silencing of subsets of genes
upon differentiation to specific lineages. However, such analysis
has not been performed to compare human cells derived from ES
and iPS that demonstrate the functional properties of mesenchy-
mal cells or stromal fibroblasts.
In the present study, we generated cells with properties of
stromal fibroblasts from multiple hiPS cell lines that were initially
reprogrammed using two different methods, and showed that their
phenotype was similar to both mature fibroblasts and to hES-
derived fibroblasts. We found that iPS-derived fibroblasts (iPDK)
and their hES-derived counterparts (EDK) shared similar cell
morphology through discrete stages of differentiation, and
displayed patterns of gene expression and cell surface markers
characteristic of mature fibroblasts. All iPS- and hES-derived cell
lines showed functional properties of fibroblasts, as seen by their
capacity to direct epidermal morphogenesis upon incorporation
into the stromal compartment of engineered human skin
equivalents. Characterization of gene promoter methylation in
EDK, iPDK, hES and iPS cell lines performed by array-based
analysis of the methylation status of over 27,000 CpG sites in these
cell types, revealed a shift towards methylation and silencing of
specific genes upon differentiation. We have linked this charac-
terization to the behavior of ES- and iPS-derived cells in engi-
neered 3D tissues to demonstrate the function of fibroblasts
derived from iPS in in vivo-like tissue environments that may
predict their capacity for regenerative medicine and use in disease
models.
Results
ES- and iPS-derived cells demonstrate morphologic and
phenotypic features of fibroblast-like cells
hiPS cells were initially generated and characterized by the
Hochedlinger lab using retroviral transduction of BJ fibroblasts
(ATCC, Inc., Manassas, VA) with five retroviral reprogramming
factors (BJ hiPS#1) [28], and additional cells were also used that
were reprogrammed using four retroviral reprogramming factors
(BJ iPS #2, LD iPS). We derived cells from iPS (iPDK2 derived
from BJ hiPS #1 and iPDK3 and iPDK4 from BJ iPS #2) using a
differentiation protocol that was previously used to generate cells
with properties of human fibroblasts from hES cells (H9 hES cell
line) [9]. In parallel, hES cells were used to derive new fibroblast
cell lines (EDK6 and EDK7) using the same differentiation
conditions. Cells derived from both hES and iPS demonstrated a
similar appearance during the sequential stages of differentiation
as seen 10 and 28 days after initiation of differentiation
(Figure 1A) and 4, 7, 14, and 21 days following differentiation
(Figure S1). At 28 days after differentiation, iPDK and EDK cell
lines showed similar fibroblast morphology, characterized by cells
with elongated and stellate shapes that maintained this morphol-
ogy over prolonged passage (Figure 1B). During differentiation,
we observed the progressive loss of pluripotency marker OCT4 in
both hES and iPS cells, and this marker was absent in fully-
differentiated cells (Figure 1C). Additionally, cell surface markers
of hES and iPS cells, TRA-1-60 and SSEA4, were lost upon
induction of differentiation, and were undetectable in stable EDK
and iPDK cell types (Figure S1B). All four cell populations
(EDK6, EDK7, iPDK2, iPDK4) showed similar expression of CD
markers, CD10, CD13, CD44, CD73, CD90, and CD166,
characteristic of MSCs and fibroblasts (Table 1). These surface
markers were found in greater than 90% of EDK6, EDK7,
iPDK2, iPDK4 cells and were comparable to the percentage of
cells expressing these markers in mature BJ fibroblasts, suggesting
a biological potential for hES and iPS-derived cells that is similar
to stromal fibroblasts. The growth of these cells was stable over
long-term culture as seen by the maintenance of cell numbers
upon serial passage and was similar to growth seen in normal
fibroblasts (Figure S2). Taken together, this data indicates that
hiPS cells can readily and reproducibly differentiate to cells with a
gene expression profile of fibroblasts in a similar manner to that
identified for hES cells.
Methylation changes upon differentiation reveal
characteristic features of commitment to a fibroblast
lineage in both iPDK and EDK cell lines
Since changes in differentiation state of pluripotent-derived cells
are often associated with DNA methylation [25], we profiled
changes in DNA methylation of CpG sites in both EDK and iPDK
upon their differentiation. We compared their methylation state
using an Illumina Methylation27 chip, which analyzes 27,000
DNA methylation sites in a large range of gene promoters both
within and outside of CpG islands. The status of each methylation
site within this data set is represented by a number from 0 to 1.0,
indicating the fraction of methylated cells present in relation to the
total number of cells within the population.
Hierarchical clustering analysis of methylation data revealed
that all of the EDK and iPDK cell types had closely-related
methylation profiles, while all pluripotent cell types clustered
together and were distinct from EDK and iPDK (Figure 2A).
Normal human fibroblasts (HFF) clustered closely with the EDK
and iPDK samples, while the foreskin-derived keratinocyte (NHK)
methylation profile was more similar to pluripotent cells studied,
unrelated to fibroblasts. Additionally, the degree of total
methylation for all the sites represented in this assay was compared
between cell samples by counting the number of CpG sites falling
within a range of b values varying in degree from highly
methylated (0.8–1.0) to unmethylated (0–0.2) (Figure 2B).
Methylation was found to be reduced in differentiated EDK and
iPDK cells when compared to the pluripotent cell types from
which they were derived. A scatter plot illustrating the compar-
ative methylation state of both EDK and iPDK showed a high
degree of correlation (R
2=0.87) indicating that the methylation
profile was similar between these two cell types (Figure 2C).
We next examined the genes that showed the greatest difference
in methylation status between undifferentiated pluripotent and
differentiated fibroblast cell types, and generated a heat map to
compare the average methylation status of EDK (n=3), iPDK
(n=3), ES (n=1), iPS (n=3) HFF (n=1) and NHK n=1). We
identified a total of 55 gene-specific methylation sites that showed
greater than a 70% difference in methylation between ES and
EDK, and a high degree of similarity to iPDK and HFF
(Figure 3A). Only 51 gene promoter regions are represented in
this dataset,asMSX1 (3 times)and CDKN2B(2times)appearedon
multiple occasions in the array. Methylation of specific promoter
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using this screen. The OCT4 and REX1 promoter CpG sites
showed consistently elevated levels of methylation upon differenti-
ation towards fibroblasts, indicating epigenetic silencing of pluripo-
tency genes as cells underwent commitment towards stable,
differentiated cell types (Figure 3B). We then analyzed the
methylation status of a group of promoter regions associated with
the expression of collagen genes, which are linked to the phenotypic
properties of extracellular matrix (ECM)-producing fibroblasts.
Several of the collagen promoter regions were demethylated in
EDK and iPDK cells when compared to hES and hiPS (COL1A1,
3A1, 4A2) (Figure 3C). Epithelial-related collagens, such as
COL17A1, remained unchanged in methylation status in EDK
and iPDK cells, and were only found to be demethylated in mature
keratinocytes. Significantly, we found that platelet-derived growth
factor-b (PDGFRb)wasconsistentlyhypomethylatedinallcellswith
properties of stromal fibroblasts, EDK and iPDK cells, indicating a
commitment to a fibroblast lineage fate (Figure 3D). Several
homeobox genes, CDX1, MSX1, and ALX homeobox 4 (ALX4),
known to regulate various stages of mesenchymal differentiation, all
showed increased promoter methylation in EDK and iPDK cells
when compared to hES cells, and were methylated at a comparable
level to that seen in mature fibroblasts (Figure 3E). CDX1
promoter has been previously identified as a hypermethylated
region in fibroblasts derived from hES[27], whileMSX1 is involved
in craniofacial development and methylation at this site appears to
be highly correlated to mesenchymal cell types [29]. The
occurrence of DNA methylation in EDK and iPDK at multiple
sites withintheMSX1 promoter may indicate an extended regionof
hypermethylation.
Figure 1. Morphology of ES and iPS cells during sequential stages of differentiation. hES and hiPS cells were induced to differentiate in
parallel, using identical differentiation procedures, and monitored for cell morphology at various stages. Representative images of hES and 2 iPS lines
during differentiation showed similar morphology at days 1, 10, and 28 of differentiation (A). iPS differentiation resulted in fewer surviving cellsa t
each stage, yet occurred on a similar time course to hES differentiation. Stable cell lines also had similar morphology at passage 8 of differentiation
(B). All images taken at 10X magnification. Immunohistochemistry during the early stages of differentiation showed the progressive loss of
pluripotency-related protein Oct-4, and Oct-4 was undetectable in differentiated cell types (C). Images taken at 20X magnification.
doi:10.1371/journal.pone.0017128.g001
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between iPDK and EDK cell lines and correlates with
methylation data
To further study the properties of iPDK and EDK cells during
their differentiation towards a fibroblast lineage fate, we analyzed
patterns of gene expression in EDK6, EDK7, iPDK2, iPDK4 after
eight passages on Type I Collagen-coated plates and compared
them to undifferentiated hiPS and hES cells from which they were
derived and to foreskin-derived fibroblasts (BJ and HFF).
Expression of OCT4, SOX2 and NANOG were significantly
down-regulated during differentiation in all EDK and iPDK cell
lines when compared to hES and iPS cells, indicating loss of
pluripotency upon differentiation (Figure 4A). Additionally,
expression of the neural precursor gene nestin was significantly
down-regulated in all EDK and iPDK cells upon their
differentiation, suggesting they did not undergo commitment to
a neural fate (Figure 4A). In contrast, the expression of genes
commonly associated with mesenchymal cells and fibroblasts,
including vimentin (VIM) and platelet-derived growth factor
receptor-b (PDGFRb), were consistently upregulated in EDK and
iPDK cells following differentiation (Figure 4B). This data
correlates with the results from the methylation screen that
showed a decrease in methylation of the PDGFRb promoter when
both iPS and hES are differentiated to iPDK and EDK cell lines
(Figure 3C). Type I collagen (COLIA, COLIA2) was also
significantly upregulated in iPS- and hES-derived cell lines
following their differentiation (Figure 4B), consistent with a
decrease in the promoter methylation of COL1A1 seen in
differentiated cell types (Figure 3D). Expression levels of VIM
and COL1A1/2 were also comparable to those seen in mature
Table 1. Flow Cytometric Analysis of ES- and iPS-derived
Cells.
Marker Control ES-derived iPS-derived
BJ EDK6 EDK7 iPDK2 iPDK4
CD10 99.8 98.1 100 99.9 96.5
CD13 100 99.7 96.7 90.2 99.1
CD44 99.9 96.2 99.9 99.9 99.8
CD73 99.8 99.8 99.9 99.9 99.7
CD90 100 90.4 100 100 99.9
CD166 99.7 98.8 99.9 99.9 99.4
The percentages of cells positive for the cell surface markers are shown. Each
experiment is normalized to isotype control, and has been repeated at least 2
times.
doi:10.1371/journal.pone.0017128.t001
Figure 2. Global profiling of DNA methylation indicates that EDK and iPDK cells share similar gene methylation levels that are
distinct from pluripotent cell types. Cell lines were analyzed for methylation marks using the Illumina Methylation27 chip. Hierarchical clustering
analysis of degrees of methylation using a Manhattan correlation showed that hES and iPS cell lines clustered in a distinct set from differentiated iPDK
and EDK cells, as well as mature fibroblasts and keratinocytes (A). The methylation status of each cell type, as assessed by the percentage of CpG sites
that fell within a range of b-values, showed that CpG islands are over 60% unmethylated, and pluripotent cells appear to have greater number of
highly-methylated CpG sites (B). A scatter plot comparing the mean level of CpG methylation in 3 EDK and 3 iPDK cell lines showed a high degree of
correlation between the two cell types (C). R
2=0.8715.
doi:10.1371/journal.pone.0017128.g002
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was lower in EDK and iPDK when compared to fibroblasts.
Another marker of fibroblasts, Thy-1, showed higher expression in
the hES-derived cells compared to iPS-derived lines, but we also
observed significant variability in expression in different lines of
mature fibroblasts that were tested.
iPDK and EDK both support the development and
maturation of keratinocytes when incorporated into the
stromal compartment of human skin equivalents. In light
of the fibroblast phenotype seen for both EDK and iPDK cells, we
next studied whether these cells could contribute to normalized
tissue morphogenesis of human skin equivalents (HSEs) when
incorporated into the stromal compartment of engineered tissues.
These tissues can serve as an in vitro surrogate of human skin that
have been previously used to study the capacity of fibroblasts to
support the growth and differentiation of the surface epithelium
[30,31]. EDK and iPDK cell lines were incorporated into collagen
gels and were grown at an air-liquid interface for 10 days, with
foreskin-derived, human keratinocytes (NHK) on their surface.
Tissues incorporating either iPDK or EDK cells in the stromal
compartment showed a similar degree of epithelial morphogenesis
on their surface that included a fully-differentiated epithelium
demonstrating a distinct basal layer and a multi-layer tissue
showing skin-like architecture (Figure 5D,G,J,M). All tissues
showed a similar degree of morphologic differentiation and
thickness that was similar to control tissues that developed in the
presence of mature fibroblasts (Figure 5A). All EDK and iPDK
cell lines demonstrated a fibroblastic morphology in collagen gels
that was similar to the morphology of HFF cells, indicating that
both hES- and iPS-derived cells types behaved similarly to stromal
fibroblasts in collagen gels. Immunofluorescence staining of tissues
for fibroblast-specific markers showed the expression of Thy-1 in
EDK and iPDK in the connective tissue (Figure 5E,H,K).
Cytokeratin-18 (K18) was also detected in EDK and iPDK cells in
both 2D cultures and 3D tissues, although it was not expressed in
adult fibroblasts. The normalization of tissue phenotype and
structure was seen by the linear deposition of Type IV Collagen at
the stromal-epithelial interface, indicating the presence of a
basement membrane (Figure 5C,F,I,L,O). Tissue organization
and markers showed that both EDK and iPDK cell lines
demonstrated a fibroblast phenotype that were able to direct the
normalization of epithelial tissue phenotype.
Figure 3. Changes in DNA methylation of gene promoter regions following differentiation shows large changes in methylation
status in EDK and iPDK compared to hES and iPS. Heatmap showing 55 CpG sites which were differentially methylated by more than 70% in
both EDK and iPDK when compared to their hES cell counterparts (A). In addition, the pluripotency-related genes OCT4 and REX1 showed increased
CpG methylation in EDK and iPDK cells compared to hES and iPS cells (B). Analysis of Collagen promoter methylation showed that the COL1A1,
COL3A1 and COL4A2 promoters were demethylated upon differentiation towards fibroblasts while collagen genes expressed in epithelial cell types,
such as COL17A1, remained methylated in differentiated cell types (C). Fibroblast-related gene PDGFR-b was demethylated in differentiated cell types
(D). Differentially-methylated Hox genes, grouped by cell type, showed a distinct methylation of Hox genes related to mesenchymal lineage
commitment (E).
doi:10.1371/journal.pone.0017128.g003
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We did not find major differences between stromal cells derived
from iPS and those derived from hES cells when their step-wise
differentiation, transcriptional program and biological potency
were characterized. The similarities we observed included their
cellular morphology at distinct stages of differentiation, expression
of cell surface markers and proteins commonly seen in mature
fibroblasts, and functional in vitro tissue outcomes upon their
incorporation into engineered skin-like tissues. Our methylation
analysis revealed that both hES- and iPS-derived fibroblasts
demonstrated similar methylation patterns and showed an increase
in methylation of developmentally-regulated genes when com-
pared to pluripotent cells.
It has been shown that both hES and iPS cells have a similar
potential to differentiate to specific cell types with similar
morphologic features [4,30,32]. However, it was unclear if cells
derived from these two pluripotent stem cell sources demonstrate
similar molecular and cellular features linked to their biological
function. For example, iPS have shown a reduced differentiation
efficiency, as well as an increased variability in the potency of
individual clones derived from iPS when compared to hES cells
[8]. In addition, iPS-derived vascular and blood cells showed
decreased growth and differentiation efficiency when compared to
their hES-derived counterparts and retinal pigment epithelial cells
derived from iPS underwent senescence more rapidly than cells
derived from hES cells [4]. These studies demonstrated the need
for further functional comparison between hES and iPS-derived
cells to evaluate their similarities and differences before clinical
application of these cell types.
We utilized an in vivo-like tissue environment to study how iPS-
and hES-derived fibroblasts would behave when compared to
normal fibroblasts, demonstrating the functional capacity of EDK
and iPDK to support the development of a multilayer epithelium
in a 3D tissue context. Several other functional readouts have been
used for ES-derived cells including beating cardiomyocytes [6,6],
neuronal action potentials [33], and lipid absorption in 2D
monolayer cultures. However, incorporation of iPS-derived cells
into engineered tissues enables a more complete determination of
their lineage commitment, fate and phenotype than those
evaluated in more conventional, monolayer cultures. The
development of 3D, skin-like tissues in vitro provides a functional
readout of stromal cell capacity to provide cross-talk needed for
epithelial morphogenesis [30,31]. Our findings address a central
challenge facing clinical application of iPS-derived cells for
regenerative medicine by providing a platform to evaluate tissue
outcomes before their future therapeutic use. In conjunction with
molecular characterization needed to confirm the down-regulation
of pluripotency genes, these engineered tissues may serve as an
important screening tool to examine the safety and stability of iPS-
derived cells before transplantation. The ability to incorporate
hES- and iPS-derived cells into 3D skin-like tissues provides initial
proof-of-concept that may enable future screening of multiple
sources of hiPS clones. In addition, the ability to compare the
original fibroblast line that iPS were derived from to fibroblasts
subsequently derived from them, will help establish if these
differentiated cells retain a normalcy to their cell of origin. This
will contribute to ongoing studies aimed at fully identifying the
epigenetic regulatory elements necessary for the establishment and
maintenance of differentiated cells that will need to be stable and
safe for in vivo transplantation.
It has been shown that early-passage mouse iPS cells retain an
epigenetic memory that reflects the cell type from which they were
originally derived and may alter their in vitro differentiation
potential [34]. While studies on human iPS and hES have shown
they are nearly identical in their chromatin structure and patterns
of gene expression [1], it is unknown if these similarities will be
maintained upon their differentiation to specific cell types. With
this in mind, we have performed methylation analysis of nearly
15,000 promoter regions to compare changes in methylation that
occur upon differentiation from hES and iPS to fibroblasts (EDK
and iPDK). We found that DNA methylation patterns were similar
in both iPDK and EDK cells, and that methylation was linked to
changes in expression of genes associated with their lineage
commitment upon differentiation. These methylation patterns
clustered with foreskin-derived fibroblasts, and they were distinct
from patterns observed in undifferentiated iPS and mature adult
keratinocytes. There was an overall increase in methylation in
both EDK and iPDK cells within the promoter region of
pluripotency-related genes, indicating a silencing of pluripotent
genes that correlates with differentiation to a fibroblast phenotype
and concomitant down regulation of expression of OCT4.
Demethylation at the PDGFR-b promoter has been identified in
previous screens comparing hES cell methylation profiles to other
differentiated tissues [25], and may represent an important site of
regulation during differentiation. Similar differences in methyla-
tion have also been reported when the parental h9-hES cells were
compared to fibroblast-like cells that had spontaneously differen-
tiated from them [27]. We extend these findings here using iPS-
derived fibroblasts that allowed a more complete characterization
by comparing them to mature, human fibroblasts prior to
reprogramming. However, it is still unknown whether specific
CpG methylation sites are responsible for any differences in
functionality we observed in our 3D culture system. An important
avenue of future research will be to identify specific epigenetic
marks that can link sub-types, such as the fibroblasts we have
derived, with their functional properties.
Since numerous tissue types require the support of stromal
fibroblasts to provide appropriate cross-talk and ECM production
to maintain tissue homeostasis and enable repair, the fibroblast
cells that we derived have great potential for applications in
regenerative medicine [35]. While adult MSCs hold potential for
the isolation of such fibroblasts, their limited capacity to proliferate
and loss of differentiation potential during in vitro expansion
restricts their ability to serve as a source of fibroblasts. Pluripotent
stem cells offer an attractive alternative source for stromal
fibroblasts. Cells with phenotypic properties of MSCs have
previously been derived from hES and iPS cells by several
approaches [18,36]. These studies have derived MSC-like cells
that have shown biological potencies similar to adult MSC, but
have not addressed the need to differentiate and assess the function
of stromal fibroblasts. Human MSCs, some of which are found in
the stroma of skin and other tissues, have previously been shown to
express low molecular-weight cytokeratins, such as K18 [37].
Therefore, it is possible that expression of K18 in EDK and iPDK
Figure 4. Gene expression of EDK and iPDK are similar to normal fibroblasts and distinct from pluripotent cells. hES and hiPS cells as
well as EDK, iPDK, HFF and BJ were analyzed by real-time RT-PCR (n=3) and values were normalized to expression in hES cells. The pluripotency gene
OCT4, SOX2 and NANOG were expressed in ES and iPS cells, and were absent in all ES and iPS-derived cells, and EDK and iPDK cells did not express
neural stem cell marker Nestin (A). In contrast, genes characteristic of fibroblasts, including vimentin (VIM) Type I collagen (COLIA1) and platelet-
derived growth factor-beta (PDGFRB) were all upregulated in EDK and iPDK cell lines compared to pluripotent cells from which they were derived (B).
doi:10.1371/journal.pone.0017128.g004
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MSC-like cells.
Our demonstration that iPS-derived cells can be differentiated
to cells with functional features of stromal fibroblasts suggests they
harbor a therapeutic potential that is distinct from MSC-like cells.
While our analysis has revealed that iPS- and hES-derived
fibroblasts are distinct from the pluripotent cells from which they
were derived, it is possible that a small number of latent,
pluripotent cells may be retained in these differentiated cell
populations that were not identified by immunofluorescence or
RT-PCR. The therapeutic implications of such residual cells have
been lessened by the existence of several recently-developed
reprogramming techniques that utilize excisable or non-integrat-
ing viral vectors that may further improve the safety of these cells
for human transplantation. Beyond this, the growth of these
differentiated cells in engineered 3D tissues may also increase our
Figure 5. EDK and iPDK support the development of a fully-differentiated epithelium when incorporated into the stroma of 3D Skin
Equivalents. Fibroblast-like cells from independent differentiations of ES and iPS cells were incorporated into a collagen gel and allowed to
contract. The collagen gel was then seeded with foreskin keratinocytes and grown at an air-liquid interface. H&E staining of tissues revealed that EDK
and iPDK cells within tissues displayed an elongated morphology in the collagen gel that supported the growth and differentiation of keratinocytes
(D,G,J,M) similar to control foreskin-derived fibroblasts (A). Immunostaining of these tissues shows the expression of fibroblast marker Thy-1 (green)
in the stromal compartment of all tissues, as well as K18 (red) within ES- and iPS-derived cells (B,E,H,K,N). Basement membrane marker, Type IV
collagen (red) was localized to the region between the stromal and epidermal compartment, indicating the establishment of the basement
membrane in these tissues (C,F,I,L,O).
doi:10.1371/journal.pone.0017128.g005
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before their in vivo therapeutic application. Since the aging process
is known to limit the differentiation potential and survival of adult
MSCs [38], iPS-derived cells with features of fibroblasts may be an
important source for future therapeutic applications to augment
repair and regeneration. Further elucidating the molecular
features that define these iPS- and ES-derived fibroblasts following
differentiation will allow us to fine-tune the engineering of specific




hiPS lines were expanded and maintained under the same
conditions as described for maintenance of hES cells [39]. BJ hiPS
#1 were derived and characterized as described [28], and new
lines of hiPS cells were provided by Dr. Laurence Daheron, and
generated from human foreskin cells (BJ cell line) (ATCC, Inc.,
Manassas, VA). The H9 line of hES cells used in this study were
purchased from the WiCell Institute (Madison, WI). All patient-
derived cells used for this study were derived from anonymous
donors and are not identifiable, and thus are exempt from IRB
approval. For directed differentiation, iPS or hES cells were plated
onto fomaldehylde-fixed MEFs, fed with NHK media, consisting
of 3:1 DMEM:F12 (Invitrogen, Carlsbad, CA), 5% FCII (Hyclone,
Logan, UT), 0.18 mM adenine, 8 mM HEPES, 0.5 mg/mL
hydrocortisone, 10
210 M cholera toxin, 10 ng/mL EGF, 5 mg/
mL insulin, and supplemented on days 4–7 with 0.5 nM BMP-4.
Subsequently, cells were propagated sequentially for an additional
7 days on fixed MEFs, plastic and Type I collagen (BD
Biosciences, San Jose, CA). Using this protocol, cells from 2
distinct iPS lines were differentiated and compared to H9-hES
cells differentiated in parallel. iPDK2 were derived using the iPS
cell line BJ hiPS#1, established in the lab of Konrad Hochedlinger
[40] using separate dox-inducible vectors Oct4, Sox2, Klf4, cMyc
and Nanog. iPDK3 and 4 were derived from separate clones of
hiPS cells, which were reprogrammed using 4 reprogramming
factors (Harvard Stem Cell Institute).
Real-time RT-PCR
RNA was extracted using the Qiagen RNeasy kit. The cDNA
was transcribed with 0.5 mg RNA using the Quantiscript Reverse
Transcriptase (Qiagen, Valencia, CA). For each real-time RT-
PCR reaction, we used 20 ng of cDNA, 200 nM of each primer,
and 2X SYBRgreen (Applied Biosystems, Foster City, CA) and
samples were run on the Bio-Rad CFX96 Real-Time PCR
Detection System according to manufacturers’ instructions. The
relative level of gene expression was assessed using the 2
-DDCt
method and results are presented as an average of 3 experiments.
Error bars represent standard deviation of a relative quantity, and
were calculated using formulas provided in the Bio-Rad
Instruction Manual. The following oligonucleotide primer se-
quences were used: GAPDH-F1 – 59 tcgacagtcagccgcatcttcttt 39,
GAPDH-R1 – 59 accaaatccgttgacctt 39 nestin-F1 – 59 tgaaggg-
caatcacaacagg, nestin-R1 – 59 tgaccccaacatgacctctg 39, OCT4-F –
59 AGCGAACCAGTATCGAGAAAC 39, OCT4-R – TTACA-
GAACCACACTCGGAC, THY1-F – 59 CCCGCAATCCCT-
CAAACCT 39, THY1-R – 59 GCAAGGATGACCCCTCCAGT
39, PDGFRb-F – 59 gtggtgatctcagccatcct 39, PDGFRb-R - 59 cc-
gacataagggcttgctt 39, VIM-F – 59 attccactttgcgttcaagg 39, VIM-R
–5 9 cttcagagagaggaagccga 39, COL1A1-F – 59 cctcctgacgcacggc-
caag 39, COL1A1-R – 59 ccctcgacgccggtggtttc 39, SOX2-F – 59
GTTGTCAAGGCAGAGAAGAG 39, SOX2-R – 59 GAGA-
GAGGCAAACTGGAATC 39, NANOG-F – 59 GAACTCTC-
CAACATCCTGAACCTC 39, NANOG-R 59 CCTTCTGCG-
TCACACCATTGC 39.
3-Dimensional (3D) tissue fabrication
Control tissues were grown using human keratinocytes (NHK)
derived from foreskin that were first cultured in 2D, monolayer
culture on irradiated 3T3 fibroblasts. Foreskin fibroblasts were
grown in media containing Dulbecco’s Modified Eagle’s Medium
(DMEM) and 10% fetal calf serum. Tissues were grown by adding
foreskin fibroblasts or ES-derived, EDK1 cells to neutralized Type
I Collagen (Organogenesis, Canton, MA) to a final concentration
of 2.5610
4 cells/ml. Three ml of this mixture was added to each
35 mm well of a 6 well plate (Organogenesis, Canton, MA) and
incubated for 7 days in media containing DMEM and 10% fetal
calf serum, until the collagen matrix showed no further shrinkage.
5610
5 NHK cells were seeded onto the collagen matrix and tissues
were maintained submerged in low-calcium epidermal growth
media for 2 days, submerged for 2 days in normal calcium media,
and then raised to the air–liquid interface for an additional 8 days
by feeding from below as previously described [30].
Immunocytochemistry and frozen section staining
EDK and iPDK cells were grown on Type I Collagen-coated
coverslips, fixed in 4% paraformaldehyde and permeabilized using
0.1% Triton X-100. Staining was performed using primary
antibodies directed against OCT-4 (Santa Cruz, Santa Cruz,
CA), TRA-1-60 (Abcam, Cambridge MA), SSEA-4 (Millipore,
Billerica, MA), K18 (Abcam, Cambridge, MA), or Thy-1
(Millipore, Billerica, MA) for 1 hour followed by Alexa 488-
conjugated goat anti-rabbit or Alexa 594-conjugated goat anti-
mouse secondary antibodies (Invitrogen, Carlsbad, CA) for
1 hour. For immunohistochemistry, tissues were frozen in
O.C.T. compound (Sakura Finetek USA, Torrance, CA) and
8 mm sections were fixed in 4% paraformaldehyde and immuno-
stained using the same protocol as above. Coverslips and tissues
were counterstained with DAPI in Vectashield mounting medium
(Vector, Burlingame, CA). Hematoxylin and Eosin (H&E) staining
for morphologic analysis was performed on paraffin-embedded
tissues that were sectioned at 8 mm thickness. Images were
captured using a SPOT RT camera and a Nikon Eclipse 80i
microscope.
Flow Cytometry
EDK and iPDK cell lines were harvested, resuspended in 2%
FBS in PBS, and stained with PE-conjugated anti -CD73, -CD10,
-CD13, -CD44, -CD73, CD166, and -IgG1k (BD Pharmingen).
Cells were incubated for 40 minutes at 4uC in the dark and washed
with 2% FBS in PBS solution. All data was generated using a
FACSCalibur (Becton Dickinson) and analyzed using CellQuest
(Becton Dickinson) and Summit V4.3 software (Dako). Analysis
was performed on 200,000 cells per sample and positive expression
was defined as the level of fluorescence greater than 90% of the
corresponding isotype control IgG1k (BD Biosciences) or the
corresponding unstained cell samples.
DNA Methylation Profiling
Methylation analysis was performed using the Infinium Human
Methylation27 BeadChip (Illumina Inc.), analyzing 27,578
individual CpG sites. EDK and iPDK cell lines were expanded
for 6 passages on Type I collagen to establish stable cell lines.
Undifferentiated hES and iPS cell lines, as well as NHK and HFF
cell types, were used as control and reference samples. DNA was
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using the EZ DNA Methylation Kit (Zymo). Converted DNA was
processed and hybridized to the Infinium Methylation Chip
according to manufacturers’ instructions, scanned on an Illumina
BeadArray Reader (Illumina Inc.) and analyzed using GenomeS-
tudio Software (Illumina Inc.). Samples were grouped as follows:
hES, iPS (iPS#12,iPS#3,iPS#4), EDK (EDK6,EDK7,EDK9),
iPDK (iPDK2,iPDK3,iPDK4), BJ, NHK. Probe sets for each
methylation site are specific for both methylated and unmethy-
lated DNA fragments. Each methylation data point is represented
as a b-value, corresponding to the fraction of cells within the total
population with CpG methylation.
Supporting Information
Figure S1 Morphology of ES and iPS cells during
multiple time-points of differentiation show similar
morphology. hES and hiPS cells were induced to differentiate
in parallel, and monitored for cell morphology at various stages of
differentiation in addition to those described in Figure 1 (A). iPS
differentiation was morphologically analogous to ES differentia-
tion in many areas of the differentiating culture, and the resultant
cell populations were all positive for K18 (green). All images taken
at 10X magnification. In addition to morphology, immunohisto-
chemistry demonstrated the progressive loss of pluripotency-
related surface markers TRA-1-60 and SSEA-4, and these markers
was undetectable in differentiated cell types (B). Images taken at
20X magnification.
(TIF)
Figure S2 Growth of EDK, iPDK, and BJ fibroblasts
upon serial passage in culture. The growth of EDK and
iPDK cells was tracked over 12 passages and compared to normal
fibroblasts. At each passage, cells were trypsinized, counted using a
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